Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Inward Investment
Return to: PBR Home | Inward Investment | News
Search Refinements

Inward Investment News

View news from other Pharmaceutical sectors:
61-75 of 421 results
OPKO Health to take over Cytochroma
By PBR Staff Writer
Multinational pharmaceutical and diagnostics company OPKO Health has signed a definitive agreement to acquire Cytochroma.
Inward Investment > News
MorphoSys divests AbD Serotec to Bio-Rad
By PBR Staff Writer
Germany based MorphoSys has closed the transaction of selling its AbD Serotec segment to Bio-Rad.
Inward Investment > News
LGC takes over Quotient bioanalytical sciences division
By PBR Staff Writer
LGC has reached an agreement to acquire Cambridgeshire-based Quotient Bioresearch's bioanalytical sciences division.
Inward Investment > News
Perrigo acquires remaining shares of Cobrek
By PBR Staff Writer
Perrigo has signed a definitive merger agreement as well as has acquired Cobrek Pharmaceuticals, an US-based drug development company, for nearly $45m on a cash free and debt free basis.
Inward Investment > News
Parexel acquires Liquent
By PBR Staff Writer
Pharmaceutical services company Parexel International has acquired all the outstanding equity securities of Liquent, a provider of Regulatory Information Management (RIM) solutions.
Inward Investment > News
OPKO Health agrees to acquire Silcon Comércio
By PBR Staff Writer
OPKO Health has signed a definite agreement to acquire Sao Paulo, Brazil based pharmaceutical company Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos.
Inward Investment > News
Rosetta to acquire minority stake in Karolinska
By PBR Staff Writer
Karolinska Development has said that a syndicate led by Rosetta Capital will acquire a minority share in Karolinska's holdings in 13 of its 25 portfolio companies for SEK 220m($33.5m).
Inward Investment > News
Novartis acquires Dendreon immunotherapy manufacturing facility
By PBR Staff Writer
Dendreon Corporation has sold its immunotherapy manufacturing facility (IMF) in Morris Plains, New Jersey, US, to Novartis Pharmaceuticals for $43m.
Inward Investment > News
Takeda to sell non-Colcrys URL Pharma to Sun Pharmaceutical
By PBR Staff Writer
Takeda Pharmaceuticals U.S.A.(TPUSA) has signed a definitive agreement with Caraco Pharmaceutical Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, to sell its non-Colcrys (colchicine, USP) URL Pharma generic business.
Inward Investment > News
Bio-Rad to take over AbD Serotec
By PBR Staff Writer
Bio-Rad Laboratories has entered into an agreement to purchase a division of MorphoSys, AbD Serotec, for euro 53m.
Inward Investment > News
ICIG acquires pharmaceutical ingredients activities of Tessenderlo
By PBR Staff Writer
Tessenderlo Group has completed the sale of its pharmaceutical ingredients activities in Calaire, France and Farchemia, Italy, to International Chemical Investors Group (ICIG), a private industrial holding company.
Inward Investment > News
Maine Manufacturing purchases certain GE laboratory filter, membrane business assets
By PBR Staff Writer
Life science and diagnostics manufacturing firm Maine Manufacturing has purchased laboratory filter and membrane business assets from GE.
Inward Investment > News
Sygnis acquires X-Pol Biotech
By PBR Staff Writer
Sygnis Pharma has completed the acquisition of Spanish company, X-Pol Biotech.
Inward Investment > News
Essex Woodlands opens healthcare investment office in China
By PBR Staff Writer
Essex Woodlands has opened a new office in Shanghai, China, to focus on healthcare investments in pharmaceuticals, medical technology, services and information technology.
Inward Investment > News
Pfizer takes over NextWave Pharmaceuticals
By PBR Staff Writer
Pfizer has announced the completion of its purchase of a specialty pharmaceutical company NextWave Pharmaceuticals.
Inward Investment > News
61-75 of 421 results